Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
Post# of 814
Next 10
Reply Private New
Public Reply Private Reply New Post
Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

RealFooFighters

Send PM
Followers 1
Posts 70
Boards Moderated 0
Alias Born 03/12/2019

RealFooFighters

Re: None

Tuesday, 09/27/2022 11:42:36 PM

Tuesday, September 27, 2022 11:42:36 PM

Post# of 814
IDWeek 2022

Oral Encochleated Amphotericin B for Cryptococcal Meningitis:
a Phase lI Randomized Trial

Saturday, October 22, 2022
© 2:15 PM - 2:30 PM US ET

Presentinq Author(s)

Mucunguzi Atukunda, MBChB, MPH

Sub-Investigator
Infectious Diseases Institute, Makerere University
Kampala, Kampala, Uganda
Disclosure: I do not have any relevant financial / non-
financial relationships with any propretary interests.

Co-Author(s):
Enock Kagimu, MBChB
Morris K. Rutakingirwa, MBChB

https://idweek.org
Public Reply Private Reply New Post
Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MTNB News
More MTNB News
InvestorsHub NewsWire

Hollywall Entertainment, Inc. (HWAL) forms new Technology Division • HWAL • Mar 20, 2023 12:50 PM

Thunder Energies Retains Global IR Firm • TNRG • Mar 20, 2023 9:30 AM

Tudor Gold Announces Significant Upgrade to Mineral Resource Estimate for the Goldstorm Porphyry Deposit..... • TUD • Mar 16, 2023 11:56 AM

Golden Matrix Reports First Quarter Financial Results With Record Revenues of $10.78 Million • GMGI • Mar 16, 2023 9:24 AM

Swifty Global Releases Details of Its Annual Shareholder Meeting • DRCR • Mar 16, 2023 9:18 AM

Authentic Holdings, Inc., to Acquire Maybacks Global Entertainment LLC • AHRO • Mar 16, 2023 8:00 AM

Start posting your company's news
Only $200 per official company press release!